Related references
Note: Only part of the references are listed.Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson's disease
Tobias Frank et al.
BRAIN (2012)
AAV Transduction of Dopamine Neurons With Constitutively Active Rheb Protects From Neurodegeneration and Mediates Axon Regrowth
Sang Ryong Kim et al.
MOLECULAR THERAPY (2012)
A30P α-synuclein impairs dopaminergic fiber regeneration and interacts with L-DOPA replacement in MPTP-treated mice
Eva M. Szego et al.
NEUROBIOLOGY OF DISEASE (2012)
Dopaminergic Pathway Reconstruction by Akt/Rheb-Induced Axon Regeneration
Sang Ryong Kim et al.
ANNALS OF NEUROLOGY (2011)
JNK Isoforms Differentially Regulate Neurite Growth and Regeneration in Dopaminergic Neurons In Vitro
Lars Toenges et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Akt Suppresses Retrograde Degeneration of Dopaminergic Axons by Inhibition of Macroautophagy
Hsiao-Chun Cheng et al.
JOURNAL OF NEUROSCIENCE (2011)
Age and α-synuclein expression interact to reveal a dependence axons on endogenous Akt/PKB signaling
Sang Ryong Kim et al.
NEUROBIOLOGY OF DISEASE (2011)
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
Laura A. Volpicelli-Daley et al.
NEURON (2011)
Loss of striatal dopaminergic terminals during the early stage in response to MPTP injection in C57BL/6 mice
Akiko Muroyama et al.
NEUROSCIENCE RESEARCH (2011)
ROCKing regeneration: Rho kinase inhibition as molecular target for neurorestoration
Lars Toenges et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Clinical Progression in Parkinson Disease and the Neurobiology of Axons
Hsiao-Chun Cheng et al.
ANNALS OF NEUROLOGY (2010)
The role of rho protein signaling in hypertension
Gervaise Loirand et al.
NATURE REVIEWS CARDIOLOGY (2010)
Axonal Degeneration of Nigra-striatum Dopaminergic Neurons Induced by 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine in Mice
L-H Li et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2009)
Efficacy of Rho-kinase Inhibition in Promoting Cell Survival and Reducing Reactive Gliosis in the Rodent Retina
Ayseguel Tura et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Dose translation from animal to human studies revisited
Shannon Reagan-Shaw et al.
FASEB JOURNAL (2008)
Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease
Florian Nagel et al.
JOURNAL OF NEUROCHEMISTRY (2008)
RTP801 Is Induced in Parkinson's Disease and Mediates Neuron Death by Inhibiting Akt Phosphorylation/Activation
Cristina Malagelada et al.
JOURNAL OF NEUROSCIENCE (2008)
ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cells
Paul Lingor et al.
BRAIN (2008)
Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q10 in Parkinson disease
Alexander Storch et al.
ARCHIVES OF NEUROLOGY (2007)
Presynaptic α-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies
Michael L. Kramer et al.
JOURNAL OF NEUROSCIENCE (2007)
Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease
Anju Nohria et al.
CIRCULATION RESEARCH (2006)
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease
Vincent Ries et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
TCH346 as a neuroprotective drug in Parkinsons disease: a double-blind, randomised, controlled trial
C. Warren Olanow et al.
LANCET NEUROLOGY (2006)
Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage - Results of a randomized trial of fasudil hydrochloride versus nimodipine
Jizong Zhao et al.
NEUROLOGIA MEDICO-CHIRURGICA (2006)
Direct Rho-associated kinase inhibiton induces cofilin dephosphorylation and neurite outgrowth in PC-12 cells
Zhiqun Zhang et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2006)
Axon degeneration mechanisms: Commonality amid diversity
M Coleman
NATURE REVIEWS NEUROSCIENCE (2005)
Rho kinase, a promising drug target for neurological disorders
BK Mueller et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Parkinson's prevalence estimated by a state registry
D Strickland et al.
MOVEMENT DISORDERS (2004)
Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats
K Abe et al.
CIRCULATION RESEARCH (2004)
Myosin II activity is required for severing-induced axon retraction in vitro
G Gallo
EXPERIMENTAL NEUROLOGY (2004)
Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation
T Dehmer et al.
JOURNAL OF NEUROCHEMISTRY (2004)
TCH346 prevents motor symptoms and loss of striatal FDOPA uptake in bilaterally MPTP-treated primates
G Andringa et al.
NEUROBIOLOGY OF DISEASE (2003)
NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
DC Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Targeting programmed cell death in neurodegenerative diseases
M Vila et al.
NATURE REVIEWS NEUROSCIENCE (2003)
Suppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates
JF Borisoff et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Axon pathology in neurological disease: a neglected therapeutic target
MP Coleman et al.
TRENDS IN NEUROSCIENCES (2002)
Neuroscience - Axonal self-destruction and neurodegeneration
MC Raff et al.
SCIENCE (2002)
The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety
S Przedborski et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Specificity and mechanism of action of some commonly used protein kinase inhibitors
SP Davies et al.
BIOCHEMICAL JOURNAL (2000)
Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice
LL Zou et al.
NEUROSCIENCE LETTERS (2000)
Share Paper
